Assessment of major gaps

Dec 19, 2019

Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.

Recent News

Urology Awareness Month

Urology Awareness Month

Primary neuroendocrine tumours in the genitourinary tract are rare, comprising approximately 1-2% of all genitourinary malignancies.

read more
National COVID Cancer survey

National COVID Cancer survey

Further to our News Item last week (15th Sept) - here is an update and the link required to get involved: National COVID Cancer survey To improve the understanding of the protection provided by antibodies generated following COVID-19 infection and vaccination in...

read more